Canada now supplies more than half of all medical cannabis imported into Germany. In Q1 2026, Germany imported 50,539 kg of cannabis flower, with Canadian producers accounting for 53% of that volume, a figure that reflects both the depth of Health Canada's regulatory infrastructure and the quality of Canadian indoor flower that European pharmacies have come to expect. For a Licensed Producer looking to enter or scale in the German market, the path is well-defined. The compliance steps are demanding, but they are predictable.
This guide covers every requirement a Canadian LP needs to satisfy before shipping flower to Germany: EU-GMP certification, BfArM narcotic import permits, Health Canada export approvals, phytosanitary documentation, and the supply chain decisions that determine whether your first shipment clears customs or arrives smoothly at a Frankfurt distributor.
Why Germany Is the Priority Export Market for Canadian LPs
Germany's import quota was raised to 270 tonnes for 2026, and market forecasts project annual imports of 600 tonnes by 2028-2029. Germany currently has only three licensed domestic cultivation operations, meaning the country will remain heavily import-dependent for the foreseeable future. Canadian producers benefit from a regulatory recognition framework that European importers understand: Health Canada's Good Production Practices (GPP) requirements are broadly equivalent to EU-GMP standards, which simplifies certification for facilities already operating to a high standard.
The economics are also compelling. Canada's domestic excise tax of $1 per gram does not apply to exports, which meaningfully improves margin on international shipments. For premium indoor flower with strong cannabinoid profiles, German medical pharmacy prices represent a significant uplift over domestic wholesale.
The Canada-to-Germany Compliance Path: 5 Requirements
Before your first shipment can enter the German medical channel, you need to satisfy five distinct compliance requirements. These can be pursued in parallel once EU-GMP certification is in progress, but the certification itself is the long-lead item that determines your timeline.
Requirement 1: EU-GMP Certification for Your Canadian Facility
EU-GMP certification is non-negotiable for direct export to Germany. Companies importing cannabis into the European market must ensure their products are manufactured at an EU-GMP certified facility. Germany's Bundesopiumstelle (BfArM) will not approve import of product from a facility that lacks a valid EU-GMP certificate.
The certification is issued by a national competent authority from an EU member state following an on-site inspection of your Canadian facility. Germany's BfArM, Portugal's Infarmed, and Denmark's DKMA have all conducted international EU-GMP inspections at Canadian sites. The process typically takes 12 to 18 months from initial application to certificate issuance. Facilities already operating under Health Canada's Good Production Practices framework tend to have a smoother path, as many documentation and process requirements overlap.
Requirement 2: GACP Compliance at the Cultivation Level
GACP (Good Agricultural and Collection Practices), published by the European Medicines Agency, governs cultivation. German pharmacy channels require both: EU-GMP compliance at the manufacturing level and GACP compliance at the cultivation level. If your facility already maintains cultivation records required under the Cannabis Act and Cannabis Regulations, producing GACP-aligned documentation is largely a matter of formatting and supplementation, not a fundamental operational change.
Requirement 3: Health Canada Export Permit
Under the Cannabis Act and Canada's obligations under the Single Convention on Narcotic Drugs, each export shipment requires a Health Canada export permit. This permit is shipment-specific and cannot be obtained until BfArM has issued the German narcotic import permit. For most shipments, the German import permit takes four to eight weeks once BfArM receives a complete application from your German importer partner. Plan your production scheduling around this sequencing dependency.
Requirement 4: BfArM Narcotic Import Permit
The German importer (not the Canadian LP) applies for the narcotic import permit from BfArM. This is a key structural point: you need an established German importer partner with the regulatory standing to apply for and hold these permits. The permit is issued per shipment, specifying quantity, product type, exporting country, and receiving facility. BfArM clarified its cultivar approval process following increased EU-GMP scrutiny in late 2025, so confirm with your German partner that your specific cultivar has received BfArM recognition before finalizing shipment quantities.
Requirement 5: Phytosanitary Certificate and Batch Documentation
Each shipment requires a phytosanitary certificate issued by the Canadian Food Inspection Agency (CFIA), confirming the product meets Germany's plant health requirements. This is in addition to the Certificate of Analysis (COA) from an ISO/IEC 17025-accredited laboratory, covering cannabinoid potency, moisture, residual solvents, pesticide residues, heavy metals, microbial contamination, and mycotoxins.
Supply Chain Structure: Direct Export vs. Portuguese GMP Processing
Until recently, many Canadian LPs that lacked direct EU-GMP certification routed product through Portuguese contract manufacturing organisations, which processed Canadian-origin flower under EU-GMP conditions before re-exporting to Germany. This model accounted for a significant share of Canada's export volume through Portugal in 2024 and early 2025.
That dynamic has shifted sharply. By early 2026, Portuguese imports of Canadian dried cannabis flower had declined substantially from their 2025 peak, as more Canadian LPs obtained direct EU-GMP certification for their own facilities. German importers now actively favour suppliers who hold EU-GMP certification at the source. If you're planning your EU entry strategy today, building toward direct certification is the more defensible long-term position, even if a Portuguese CMO relationship gets you to market faster in the near term.
What German Importers Evaluate in a Canadian Supplier
When a German importer reviews a potential Canadian supply relationship, the compliance credentials are necessary but not sufficient. The operational questions they're also asking include:
- Batch-to-batch consistency in cannabinoid potency and terpene profile
- Reliable supply capacity to meet ongoing pharmacy demand without gaps
- Full batch traceability from cultivation through to packaged product
- Competitive pricing in Euros with predictable foreign exchange terms
- Responsiveness and a dedicated export contact
For Canadian indoor producers, the quality story is a genuine differentiator. German pharmacy patients and prescribers have developed clear preferences for large-format, hand-trimmed flower with consistent terpene expression. Machine-trimmed or poorly handled product, regardless of cannabinoid numbers, does not hold up well in the German market's quality expectations.
AlphaLeaf Corp is a Health Canada Licensed Producer based in Montreal, producing premium indoor dried cannabis flower with export authorisation. Our flagship cultivar, Ice Cream Cake, delivers 30.3% THC with a refined terpene profile developed through our Montreal indoor facility. Every batch is hand-trimmed, ISO-certified tested, and fully traceable from cultivation through export documentation. Contact our international team at alphaleaf.ca/#international or review our certifications at alphaleaf.ca/#certifications.
Frequently Asked Questions
Does Canada export cannabis to Germany?
Yes. Canada is Germany's largest single source of imported medical cannabis. In Q1 2026, Canada supplied 53% of Germany's total flower imports, which reached 50,539 kg for the quarter. Canadian Licensed Producers holding EU-GMP certification and Health Canada export authorisation can ship directly to licensed German importers.
What certification does a Canadian LP need to export cannabis to Germany?
The primary certification required is EU-GMP, issued by a national competent authority from an EU member state following an inspection of the Canadian facility. GACP-compliant cultivation documentation is also expected, alongside a valid Health Canada export permit for each shipment.
Who issues the import permit for cannabis entering Germany?
BfArM (the Bundesopiumstelle, Germany's Federal Opium Agency) issues narcotic import permits for cannabis entering Germany. The permit is issued to the German importer, not the Canadian exporter, and must be in place before Health Canada will issue the corresponding Canadian export permit.
How long does it take to get EU-GMP certification for a Canadian cannabis facility?
The process typically takes 12 to 18 months from initial application to certificate issuance, depending on the inspecting authority and the facility's existing quality management infrastructure. Facilities already operating under Health Canada's Good Production Practices (GPP) framework tend to progress more efficiently through the EU-GMP audit process.
What documentation is required for each cannabis shipment to Germany?
Each shipment requires: a Health Canada export permit, a BfArM narcotic import permit (held by the German importer), a phytosanitary certificate from the CFIA, a Certificate of Analysis from an ISO/IEC 17025-accredited laboratory, and EU-GMP batch release documentation.
Can Canadian LPs export to Germany without EU-GMP certification?
No. EU-GMP certification is a prerequisite for importing cannabis into Germany through pharmacy channels. While some producers historically routed product through Portuguese processing facilities, German importers now strongly prefer to source from directly EU-GMP-certified Canadian facilities.
